E. DURCAN Et Al. , "Fibroblast Growth Factor Receptor-4 Expression in Pituitary Adenomas is Associated with Aggressive Tumor Features," EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.130, no.2, pp.125-133, 2022
DURCAN, E. Et Al. 2022. Fibroblast Growth Factor Receptor-4 Expression in Pituitary Adenomas is Associated with Aggressive Tumor Features. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.130, no.2 , 125-133.
DURCAN, E., Keskin, F. E., ÖZKAYA, H. M., ŞİROLU, S., Sahin, S., Korkmaz, O. P., ... Gazioglu, N.(2022). Fibroblast Growth Factor Receptor-4 Expression in Pituitary Adenomas is Associated with Aggressive Tumor Features. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.130, no.2, 125-133.
DURCAN, Emre Et Al. "Fibroblast Growth Factor Receptor-4 Expression in Pituitary Adenomas is Associated with Aggressive Tumor Features," EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.130, no.2, 125-133, 2022
DURCAN, Emre Et Al. "Fibroblast Growth Factor Receptor-4 Expression in Pituitary Adenomas is Associated with Aggressive Tumor Features." EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.130, no.2, pp.125-133, 2022
DURCAN, E. Et Al. (2022) . "Fibroblast Growth Factor Receptor-4 Expression in Pituitary Adenomas is Associated with Aggressive Tumor Features." EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.130, no.2, pp.125-133.
@article{article, author={Emre DURCAN Et Al. }, title={Fibroblast Growth Factor Receptor-4 Expression in Pituitary Adenomas is Associated with Aggressive Tumor Features}, journal={EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES}, year=2022, pages={125-133} }